Assignee profile:

Biocrine AB

City:

Solna

Country:

Sweden

Published Applications:

16

Last publication date:

2023-03-16

Patent Grants:

16

Last grant date:

2026-03-24

Top Inventors for applications by Biocrine AB

These are the the leading inventors for applications assigned to Biocrine AB:

Recent patent applications by Biocrine AB

Biocrine AB based in Solna, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-03-16 ✅ Patent 12,584,904 granted on 2026-03-24
US20230079688A1
Physics

Methods for monitoring physiological status of a body organ

#2 | 2019-10-17 ✅ Patent 11,519,902 granted on 2022-12-06
US20190317076A1
Physics

Methods for monitoring physiological status of a body organ

#3 | 2019-03-07 ✅ Patent 10,338,060 granted on 2019-07-02
US20190072542A1
Physics

Methods for monitoring physiological status of a body organ

#4 | 2019-03-07 ✅ Patent 10,493,108 granted on 2019-12-03
US20190070316A1
Human necessities

Non-invasive in vivo imaging and methods for treating diabetes

#5 | 2018-08-23 ✅ Patent 10,695,425 granted on 2020-06-30
US20180236069A1
Human necessities

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

#6 | 2017-11-23 ✅ Patent 10,226,530 granted on 2019-03-12
US20170333555A1
Human necessities

Methods for treating and/or limiting development of diabetes

#7 | 2017-10-05 ✅ Patent 9,968,675 granted on 2018-05-15
US20170281763A1
Human necessities

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

#8 | 2017-09-28 ✅ Patent 10,228,364 granted on 2019-03-12
US20170276667A1
Physics

Methods for monitoring physiological status of a body organ

#9 | 2017-05-18 ✅ Patent 10,060,935 granted on 2018-08-28
US20170138968A1
Physics

ApoIII and the treatment and diagnosis of diabetes

#10 | 2017-01-19 ✅ Patent 9,702,867 granted on 2017-07-11
US20170016883A1
Physics

Methods for monitoring physiological status of a body organ

#11 | 2017-01-05 ✅ Patent 10,207,012 granted on 2019-02-19
US20170000907A1
Human necessities

Non-invasive in vivo imaging and methods for treating type I diabetes

#12 | 2016-08-11 ✅ Patent 9,700,617 granted on 2017-07-11
US20160228545A1
Human necessities

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

#13 | 2016-07-07 ✅ Patent 9,744,232 granted on 2017-08-29
US20160193331A1
Human necessities

Methods for treating and/or limiting development of diabetes

#14 | 2014-01-02 ✅ Patent 9,068,973 granted on 2015-06-30
US20140004102A1
Physics

Methods for treating and/or limiting development of diabetes

#15 | 2012-12-27 ✅ Patent 8,557,513 granted on 2013-10-15
US20120328630A1
Human necessities

Methods for treating and/or limiting development of diabetes

#16 | 2011-01-27 ✅ Patent 8,466,185 granted on 2013-06-18
US20110021584A1
Human necessities

Methods and assays for detecting and treating hypoglycemia

Also check out BioCrine AB's (Solna, Sweden) applicant profile with 16 patent applications submitted.

AssigneeID:

391223 ⎘